These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 59517)

  • 41. CEREBRAL VASCULAR INSUFFICIENCY.
    HURWITZ LJ
    Gerontol Clin (Basel); 1964; 6():81-92. PubMed ID: 14102816
    [No Abstract]   [Full Text] [Related]  

  • 42. SUPERIORITY OF HEPARIN OVER PROTHROMBIN DEPRESSANTS IN THE TREATMENT OF THROMBOPHLEBITIS AND ITS SEQUELAE.
    LAUFMAN H
    Surg Clin North Am; 1964 Feb; 44():195-209. PubMed ID: 14116104
    [No Abstract]   [Full Text] [Related]  

  • 43. Evaluation of a simple dosage scheme for transition from phenprocoumon to warfarin in oral anticoagulation.
    Kristiansen C; Lassen JF; Dahler-Eriksen BS; Dahler-Eriksen K; Larsen TB; Brandslund I
    Thromb Res; 2000 Apr; 98(2):157-63. PubMed ID: 10713317
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration.
    Andreasen PB; Vesell ES
    Clin Pharmacol Ther; 1974 Dec; 16(6):1059-65. PubMed ID: 4611464
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of administration of estrogen or diphenylhydantoin on the kinetics of diphenylhydantoin in man.
    Fernandez-Pol JA; Zaninovich AA
    J Nucl Med; 1975 Apr; 16(4):305-8. PubMed ID: 803558
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diphenylhydantoin elimination kinetics in overdosed children.
    Garrettson LK; Jusko WJ
    Clin Pharmacol Ther; 1975 Apr; 17(4):481-91. PubMed ID: 1122689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. USE OF ANTICOAGULANTS IN THE PREVENTION OF VENOUS THROMBOEMBOLIC DISEASE IN POSTOPERATIVE PATIENTS.
    BELDING HH
    Arch Surg; 1965 Apr; 90():566-73. PubMed ID: 14267658
    [No Abstract]   [Full Text] [Related]  

  • 48. [Drug interaction during therapy with tolbutamide. The influence of some commonly used drugs on plasma level and half life in diabetic out-patients (author's transl)].
    Kolenda KD; Grille W; Johnsen K
    Med Klin; 1979 Dec; 74(50):1914-22. PubMed ID: 542176
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The enantiomers of phenprocoumon: pharmacodynamic and pharmacokinetic studies.
    Jähnchen E; Meinertz T; Gilfrich HJ; Groth U; Martini A
    Clin Pharmacol Ther; 1976 Sep; 20(3):342-9. PubMed ID: 954354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of diazepam on the biliary excretion of diphenylhydantoin in the rat.
    El-Hawari AM; Plaa GL
    J Pharmacol Exp Ther; 1977 Apr; 201(1):14-25. PubMed ID: 850136
    [TBL] [Abstract][Full Text] [Related]  

  • 51. STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: A COMPARISON OF THE PHARMACODYNAMICS OF DICUMAROL AND WARFARIN IN MAN.
    O'REILLY RA; AGGELER PM; LEONG LS
    Thromb Diath Haemorrh; 1964 Apr; 11():1-22. PubMed ID: 14167102
    [No Abstract]   [Full Text] [Related]  

  • 52. OUTPATIENT ANTICOAGULATION: A PROBLEM IN LONG-TERM MANAGEMENT.
    BEINSTEIN J
    Va Med Mon (1918); 1964 Apr; 91():149-54. PubMed ID: 14140408
    [No Abstract]   [Full Text] [Related]  

  • 53. [Influence of (+)-Catechin and Dithiocarb on the Pharmacokinetics of Phenprocoumon, Tolbutamide and Three Inhalation Anesthetics in rats].
    Siegers CP; Iven H
    Arzneimittelforschung; 1982; 32(11):1437-40. PubMed ID: 6295415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of adrenergic cardiopathies by drugs. II. Anticoagulants.
    Eichbaum FW; Zyngier S
    Arch Kreislaufforsch; 1970; 62(1):65-71. PubMed ID: 4109309
    [No Abstract]   [Full Text] [Related]  

  • 55. Interaction of diphenylhydantoin and some oral hypoglycemic drugs related to carbohydrate metabolism in rats.
    Shehata MM
    Pol J Pharmacol Pharm; 1980; 32(1):11-4. PubMed ID: 7454606
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of dicumarol and marcoumar therapy with a single initial dose.
    POPOVIC LJ; VLAHCEVIC Z
    Acta Med Iugosl; 1962; 16():68-76. PubMed ID: 13972279
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical experiences with anticoagulants; a comparison of coumadin (warfarin) sodium and dicumarol (bishydroxycoumarin).
    NICHOLSON JH
    Angiology; 1957 Oct; 8(5):456-65. PubMed ID: 13478915
    [No Abstract]   [Full Text] [Related]  

  • 58. Biliary excretion of diphenylhydantoin in the rat. Time-course studies.
    Inaba T; Umeda T
    Drug Metab Dispos; 1975; 3(2):69-73. PubMed ID: 236160
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The in vivo effects of acenocoumarol, phenprocoumon and warfarin on vitamin K epoxide reductase and vitamin K-dependent carboxylase in various tissues of the rat.
    de Boer-van den Berg MA; Thijssen HH; Vermeer C
    Biochim Biophys Acta; 1986 Oct; 884(1):150-7. PubMed ID: 3490277
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural forms of phenprocoumon and warfarin that are metabolized at the active site of CYP2C9.
    He M; Korzekwa KR; Jones JP; Rettie AE; Trager WF
    Arch Biochem Biophys; 1999 Dec; 372(1):16-28. PubMed ID: 10562412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.